Report an error   
Advanced Search

Screening of anxiety and depression among CKD patients using HADS.


Kristoffer Ted M. Angala

Related Institution

Baguio General Hospital and Medical Center, BGHMC

Publication Information

Publication Type
Research Report



Anxiety and depression have an overall prevalence of 54.9% among the medically-ill patients and increase to 60% among the Chronic Kidney Disease (CKD) patients due to the overlap of symptoms such as those of uremia. In addition, the detection of comorbid depression and anxiety may present a diagnostic challenge among dialysis patients. Hence, this study aims to determine the prevalence, degree, and possible association between anxiety and depression among hemodialysis patients.


This is a cross-sectional study which screened 160 enrolled Chronic Kidney (CKD) patients at Baguio General Hospital undergoing hemodialysis (HD) from August 2017 to September 2017 using the Hospital Anxiety and Depression Scale (HADS) questionnaire. Descriptive and inferential statistics was used to correlate anxiety and depression.


Enrolled in this study are middle-aged group (mean age: 49 y/o +/- 18 y/o) of whom majority are married males, as well as college graduates who do office works for a living. The population is predisposed to have CKD primarily due to Diabetes Mellitus (41.9%) and Hypertension (40.0%). The prevalence of anxiety and/or depression in the study is 130 (81.25%). On the other hand, the prevalence of depression's symptoms (N= 117, 73.13%) surmounts the prevalence of symptoms of anxiety (N=114, 71.25%), both of which were classified as mild, moderate or severe and there is a significant relationship between the two (p-value <0.00001).


The study showed a high prevalence of anxiety and depression among CKD patients undergoing HD compared to the general medically-ill population and posed a statistically significant association between them.

©2022 HERDIN PLUS. All rights reserved.